Dead cat bounce & turd polishing. No "Japan" deal No efficacy for any product No net revenues No way to avoid attempting a cap raise (execs need bonuses again for tanking value) Maybe 30 days cash in the till
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025